Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

India Takes Aim at China Pharma's Inroads into the Indian Market

publication date: Oct 6, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
The pharmaceutical business is very important to India, and India is very successful at exporting pharma products to other countries. But India is worried China may grow to dominate India’s own pharma market, taking over business that India wants to keep for itself. Last year, China exported $3.3 billion of APIs to India, while India sent just $500 million of APIs to China. India's Commerce Ministry thinks the government should intervene. More details...

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...